miR‐200c/Bmi1 axis and epithelial–mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment

Publisher: John Wiley & Sons Inc

E-ISSN: 1755-148x|28|4|431-441

ISSN: 1755-1471

Source: PIGMENT CELL & MELANOMA RESEARCH, Vol.28, Iss.4, 2015-07, pp. : 431-441

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content